BSECompany Update5 Nov 2026 · 5 Nov 2026, 06:10 pm
Please find the enclosed intimation of the Company as per the captioned subject for your reference.
AstraZeneca Pharma India Ltd · 506820
✦ AI SummaryMgmt Change
AstraZeneca Pharma India Ltd has updated the contact details of its key managerial personnel responsible for determining materiality of events and information for disclosure to stock exchanges, effective November 9, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
AstraZeneca Pharma India Ltd - 506820 - Determination Of Materiality - Details Of Key Managerial Personnel
Attachments (1)
📄pdf
Download →
2eb79e16-fd68-4164-b715-b15c743f4bac.pdf
View document text
November 5, 2026
The Manager - Listing
BSE Limited
P J Towers, Dalal Street, Fort
Mumbai - 400 001
BSE scrip code: 506820
The Manager - Listing
National Stock Exchange of India Limited
Exchange Plaza,
Bandra – Kurla Complex, Bandra (E)
Mumbai - 400 051
NSE symbol: ASTRAZEN
Dear Sir/ Madam,
Subject: Determination of materiality - Details of Key Managerial Personnel
This is to inform that, as required under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, the contact details of the Key Managerial Personnel authorised to determine the
materiality of an event and/or information for disclosure to the Stock Exchange(s), with effect from November 9,
2026, are as follows:
Sl. No. Name & Designation Contact Details
1. Mr. Praveen Rao Akkinepally Praveen.Akkinepally@astrazeneca.com
Managing Director
2. Mr. Atul Tandon Atul.Tandon@astrazeneca.com
Chief Financial Officer
3. Ms. Tanya Sanish tanya.sanish@astrazeneca.com
Company Secretary
Kindly take the above information on record.
Thanking you,
For AstraZeneca Pharma India Limited
Tanya Sanish
Company Secretary & Compliance Officer
ACS No. A25784